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from the control group was not administered antibiotic treat-
ment.  The length of antibiotic treatment in the study group 
was 4.0 while in the control group it was 4.5 days.
Pathogenic and symptomatic treatment
Both groups received some maintenance therapy. In 9 
patients this included glucose 5%, physiological serum 0.9%, 
haemodesia and arginine in 1 patient, antipyretics in 15 
patients, vitamins (ascorutin) in 29 patients, desensitizers 
in 15 patients, expectorants in 6 patients, broncholytics in 7, 
antitussives in 8, respiratory analeptics in 6, vasoconstrictive 
decongestants in 8, diuretics and corticosteroids in one pa-
tient for a day.
Conclusions
Treatment with Tamiflu and BioR in patients with A 
(H1N1) influenza was beneficial and contributed to:
· Reduction by an average of one day in the length of 
symptoms that affected the central nervous system, and 
particularly those reflecting the action of the sympa-
thetic nervous system,
· Reduction of symptoms affecting the respiratory system 
(3.8 days in the experimental group and 5.3 days in the 
control one).
· Decreased hospitalization length in patients with influ-
enza A (H1N1) (5.09 days in the experimental group 
and 6.1 in the control group).
· Decreased hospitalization length of patients with bron-
chopneumonia in the experimental group (5.2 days vs 
7 days)
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Abstract
Tooth loss compromises human oral health.  Although several prosthetic methods (such as artificial denture and dental implants) are clinical therapies 
to tooth loss problems, they are thought to have safety and usage-time issues.  Recently, tooth tissue engineering has attracted more and more attention. 
Stem cell based tissue engineering is thought to be a promising way to replace the missing tooth.  Mesenchymal stem cells (MSC) are multipotent stem 
cells which can differentiate into a variety of cell types.  The potential MSC for tooth regeneration mainly include stem cells from human exfoliated 
deciduous teeth, adult dental pulp stem cells, stem cells from the apical part of the papilla, stem cells from the dental follicle, periodontal ligament stem 
cells and bone marrow-derived mesenchymal stem cells.  This review outlines the recent progress in mesenchymal stem cell research and its use in tooth 
regeneration and oral and craniofacial applications.
Key words: mesenchymal stem cell, tooth engineering, dental pulp stem cell.
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Cтволовые клетки в стоматологии будущего
Потеря зубов ставит под угрозу человеческое здоровье.  Ткани зуба у взрослых практически не способны к самостоятельной регенерации и 
дефект эмали, возникающий в результате действия повреждающих факторов, постепенно приводит к потере зуба.  Без сомнения, современные 
технологии протезирования позволяют произвести реконструкцию даже при полном отсутствии зубов.  Однако прогресс современной 
органотипической регенеративной медицины заставляет исследователей искать новые технологии замещения зубов естественными 
трансплантатами.  Последнее время клеточная инженерия тканей зуба привлекает все больше и больше внимания.  Стволовые клетки являются 
многообещающим способом замены недостающего зуба.  Мезенхимальные стволовые клетки способны дифференцироваться в клетки костной 
ткани, что дает возможность использовать их для восстановления зуба.  Этот обзор рассматривает современные исследования стволовых 
клеток и возможность их использования для стимуляции репаративной регенерации тканей зуба.
Ключевые слова: мезенхимальная стволовая клетка, инженерия тканей зуба, стволовая клетка пульпы.
Introduction
What are stem cells?  As dentists, why should we be con-
cerned with stem cells?  How would stem cells change dental 
practice?  Is it possible to grow a tooth by tissue engineering 
using stem cells?  What should be the carrier material for stem 
cells?  Probably, development of stem cell research will, over 
time, transform dental practice in a magnitude far greater 
than did dental implants.  Metallic alloys, composites and even 
titanium implants are not permanent solutions.  In contrast, 
stem cell technology will generate native tissue analogs that 
are compatible with that of the patient’s.  Dental implants are 
not the perfect solution for replacing missing teeth as the 
healing process extends for many months and rejection of the 
implant occurs in about 5 percent of patients.  Furthermore, 
dental implants are expected to last for about 15 years [1]. 
Despite much advancement in implant technology conventi-
onal implants do not provide a truly permanent solution for a 
missing tooth.  But the answer could lie in a highly researched 
new dental technique – dental implants based on stem cell 
technologies which could be the future of implant dentistry. 
Stem cells in dental pulp were discovered in 2000 by Dr. 
Songtao Shi, a dental researcher at the National Institute of 
Health (NIH). After verification that these cells were in fact 
viable stem cells, the NIH announced the discovery in 2003.
The dentists treat patients because of infections, trauma, 
congenital anomalies or other diseases, such as orofacial 
cancer and salivary gland disorders.  Caries and periodontal 
disease remain highly prevalent disorders among humans. 
Whereas native tissue is missing in congenital anomalies, di-
seases such as caries or tumor resection result in tissue defects. 
For centuries, dentistry has been devoted to healing defects 
with durable materials or the patient’s own (autologous) tissue. 
But we now realize that metallic alloys or synthetic materials 
are not permanent solutions.  Amalgam, composites and even 
titanium dental implants can fail; and all have limited service 
time (Rahaman A., Mao J., 2005).  Why are stem cells better 
than durable implants such as titanium dental implants? 
Stem cells lead to the regeneration of teeth with periodontal 
ligament that can remodel to the host.  Why are stem cells 
superior to autologous tissue grafts?  Autologous tissue 
grafting is based on the concept that a diseased or damaged 
tissue must be replaced by like tissue that is healthy.  Thus, 
the key drawback of autologous tissue grafting is donor site 
trauma and morbidity; the harvest of healthy bone from the 
patient could be taken from the iliac crest, rib bone, chin or 
retromolar area for bone grafting needs in cleft palate, ridge 
augmentation, sinus lifting, and maxillary and mandibular 
reconstruction.  In contrast, stem cell-based therapeutic ap-
proaches may circumvent the key deficiencies of autologous 
bone grafting (Rahaman A., and Mao J., 2005).  Stem cells from 
a tiny amount of tissue, such as the dental pulp, can potentially 
be multiplied or expanded to sufficient numbers for healing 
large, clinically relevant defects.  Stem cells can differentiate 
into multiple cells lineages, thus providing the possibility that 
a common (stem) cell source can heal many tissues in the 
same patient, as opposed to the principle of harvesting healthy 
tissue to heal like tissue in association with autologous tissue 
grafting (Moioli E. K., et al., 2007).
Stem cells can be seeded in biocompatible scaffolds in the 
shape of the anatomical structure that is to be replaced.  Stem 
cells may elaborate and organize tissues in vivo, especially 
in the presence of vascularisation.  Finally, stem cells may 
regulate local and systemic immune reactions of the host in 
ways that favor tissue regeneration.  Physicians and scientists 
have recommended that umbilical cord stem cells, placental 
and amniotic fluid stem cells could be banked for potential 
application in the treatment of trauma and pathological di-
sorders [19].
The understanding of mesenchymal stem cells in the tissue 
engineering of dental, oral and craniofacial structures has 
advanced tremendously (Marion N., Mao J., 2006).  We have 
witnessed tissue engineering of the tooth, temporomandibular 
joint condyle, cranial sutures, soft tissue grafts, craniofacial 
bone and other structures in animal models.  With all that we 
have learned about stem cells and tissue engineering of dental, 
oral and craniofacial structures, we are in a position to bring 
awareness to our patients regarding the proper storage of their 
extracted teeth in conditions that will preserve craniofacial 
stem cells, including tooth-derived stem cells.  These include, 
but are not limited to, extracted wisdom teeth, deciduous 
teeth and any teeth extracted for orthodontic purposes and 
any non-infected teeth extracted.  Among postnatal tissues 
that are sources of stem cells that are obtainable without 
substantial trauma are extracted wisdom teeth, exfoliating 
or extracted deciduous teeth, teeth extracted for orthodontic 
treatment, trauma or periodontal disease.  Craniofacial stem 
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cells, including tooth-derived stem cells, have the potential, 
as do bone marrow-derived stem cells and adipose-derived 
stem cells, to cure a number of diseases that are relevant to 
dentistry as well as for medicine: diabetes, Parkinson’s disease, 
cardiac infarct etc.
Stem cells can be defined as self-replicating cells that are 
able to differentiate into at least two different cell types.  Both 
conditions must be present for a cell to be considered a stem 
cell.  For example, osteoblasts are not stem cells.  Although 
osteoblasts differentiate into osteocytes, they typically do not 
differentiate into other cell types except osteocytes.  Osteocy-
tes are not stem cells; they are end-lineage cells that typically 
neither self-replicate and not differentiate in to another cells 
type [1].
Mesenchymal stem cells (MSC)
(MSC) can be isolated from different sources.  First descri-
bed in bone marrow, MSC have been extensively characterized 
in vitro by the expression of markers such as STRO-1, CD146 
or CD44.  STRO-1 is a cell surface antigen used to identify os-
teogenic precursors in bone marrow, CD146 a pericyte marker, 
and CD44 a mesenchymal stem cell marker.  MSC possess a 
high self-renewal capacity and the potential to differentiate 
into mesoderm lineages thus forming cartilage, bone, adipose 
tissue, skeletal muscle and the stroma of connective tissues. 
The potential of dental MSC for tooth regeneration and repair 
has been extensively studied in the last years.  Below, we will 
present the mesenchymal progenitors that have been assessed 
for tooth engineering purposes, such as progenitors derived 
from teeth (adult dental pulp, apical part of papilla, dental 
follicle, periodontal ligament) (fig. 1) and bone marrow [2].
Stem cells from human exfoliated  
deciduous teeth (SHED)
The isolation of post-natal stem cells from an easily ac-
cessible source is indispensable for tissue engineering and 
clinical applications.  Recent findings demonstrated the iso-
lation of mesenchymal progenitors from the pulp of human 
deciduous incisors.  These cells were named SHED (Stem 
cells from Human Exfoliated Deciduous teeth) and exhibited 
a high plasticity since they could differentiate into neurons, 
adipocytes, osteoblasts and odontoblasts.  In vivo SHED cells 
can induce bone or dentin formation but, in contrast to dental 
pulp, DPSC failed to produce a dentin-pulp complex [3].
Adult dental pulp stem cells (DPSC)
The possibility that tooth pulp might contain mesenchy-
mal stem cells was first suggested by the observation that 
severe tooth damage that penetrates both enamel and dentine 
into the pulp stimulates a limited natural repair process, by 
which new odontoblasts are formed, which produce new 
dentine to repair the lesion (Smith A. J., Lesot H., 2001).  Pu-
tative stem cells from the tooth pulp and several other dental 
tissues have now been identified.  The first stem cells isolated 
from adult human dental pulp were termed dental pulp stem 
cells (DPSCs) [1].  They were isolated from permanent third 
molars, and exhibited high proliferation and high frequency 
of colony formation that produced sporadic, but densely cal-
cified nodules.  Additionally, in vivo transplantation into im-
Fig. 1.  Diagram of a human third molar  
as a source of dental stem cells. Because the tooth  
was in the process of erupting, root growth is incomplete, 
and the apical papilla is visible.
munocompromised mice demonstrated the ability of DPSCs 
to generate functional dental tissue in the form of dentine/
pulp-like complexes [2].  Further characterization revealed 
that DPSCs were also capable of differentiating into other 
mesenchymal cell derivatives in vitro such as odontoblasts, 
adipocytes, chondrocytes and osteoblasts (Koyama N., et al., 
2009).  DPSCs differentiate into functionally active neurons, 
and implanted DPSCs induce endogenous axon guidance, 
suggesting their potential as cellular therapy for neuronal 
disorders (Arthur A. et al., 2009).
Stem cells from the apical part of the papilla (SCAP)
Recently another type of MSCs was discovered in the 
apical papilla of human immature permanent teeth termed 
stem cells from apical papilla (SCAP) (Wataru Sonoyama, Yi 
Liu, Takayoshi Yamaza, 2008).  We found that apical papilla 
is distinctive to pulp in terms of containing less cellular and 
vascular components than those in pulp.  Cells in apical papilla 
proliferated 2- to 3-fold greater than those in pulp in organ 
cultures.  Both SCAP and DPSCs were as potent in osteo/den-
tinogenic differentiation as MSCs from bone marrows while 
weaker in adipogenic potential.  The immunophenotype of 
SCAP is similar to that of DPSCs on the osteo/dentinogenic 
and growth factor receptor gene profiles.  Double staining 
experiments showed that STRO-1 co-expressed with denti-
nogenic markers such as bone sialophosphoprotein (BSP), 
osteocalcin (OCN) and growth factors FGFR1 and TGFβRI in 
cultured SCAP.  Stem cells from the apical part of the human 
dental papilla (SCAP) have been isolated and their potential 
to differentiate into odontoblasts was compared to that of 
the periodontal ligament stem cells (PDLSC).  SCAP exhibit 
a higher proliferative rate and appears more effective than 
PDLSC for tooth formation.  Importantly, SCAP are easily 
accessible since they can be isolated from human third molars.
Stem cells from the dental follicle (DFSC)
DFSC have been isolated from follicle of human third 
molars and express the stem cell markers Notch1, STRO-1 
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and nestin.  The dental follicle is a loose of ectomesenchyme-
derived connective tissue sac surrounding the enamel organ 
and the dental papilla of the developing tooth germ before 
eruption (Ten Cate, 1998).  It is believed to contain progenitors 
for cementoblasts, PDL and osteoblasts.  Dental follicle cells 
(DFC) form the PDL by differentiating into PDL fibroblasts 
that secrete collagen and interact with fibres on the surfaces of 
adjacent bone and cementum.  DFC can form cementoblast-
like cells after transplantation into SCID mice (Handa K. et 
al., 2002).  Dental follicle progenitor cells isolated from human 
third molars are characterized by their rapid attachment in 
culture, expression of the putative stem cell markers Nestin 
and Notch-1, and ability to form compact calcifiednodules 
in vitro (Lin N. H. et al., 2008).  DFC were transplanted 
into immunocompromised mice, however, there was little 
indication of cementum or bone formation (Lin N. H. et al., 
2008).  DFC, in common with SCAP, represents cells from a 
developing tissue and might thus exhibit a greater plasticity 
than other dental stem cells.  However, also similar to SCAP, 
further research needs to be carried out on the properties and 
potential uses of these cells.
Periodontal ligament stem cells (PDLSC)
The PDL is a specialized tissue located between the ce-
mentum and the alveolar bone and has the maintenance and 
support of the teeth as a role.  Its continuous regeneration is 
thought to involve mesenchymal progenitors arising from 
the dental follicle.  PDL contains STRO-1 positive cells that 
maintain certain plasticity since they can adopt adipogenic, 
osteogenic and chondrogenic phenotypes in vitro.  It is thus 
obvious that PDL itself contains progenitors, which can be 
activated to self-renew and regenerate other tissues such as 
cementum and alveolar bone.  It was shown that cultured 
PDLSCs proliferate in higher rate on the rough surface espe-
cially at the 75μm Al2O3 particle treated surface than other 
surfaces.  Also, osteocalcin was highly expressed on the rough 
surfaces treated with 75μm and 125μm Al2O3 particles (Heo 
Y. Y., Um S., Kim S. K., Park J. M., 2011).
Bone marrow derived mesenchymal stem cells (BMSC)
BMSC have been tested for their ability to recreate perio-
dontal tissue.  These cells are able to form in vivo cementum, 
PDL and alveolar bone after implantation into defective 
periodontal tissues.  Thus, bone marrow provides an alterna-
tive source of MSC for the treatment of periodontal diseases 
(Kawaguchi H., 2004).  BMSC share numerous characteristics 
with DPSC and are both able to form bone-like or tooth-like 
structures.  However, BMSC display a lower odontogenic 
potential than DPSC (Yu J. et al., 2007), indicating that MSC 
from different embryonic origins are not equivalent.  Indeed, 
DPSC derive from neural crest cells, whereas BMSC originate 
from the mesoderm.  Furthermore, the comparison of the 
osteogenic and adipogenic potential of MSC from different 
origins shows that, even if cells carry common genetic mar-
kers, they are not equivalent and are already committed toward 
a specific differentiation pathway (Musina R. A. et al., 2006). 
Commitment could arise from conditioning of stem cells by 
their specific microenvironment or stem cell niche.
Tissue engineering
There are several areas of research for which dental stem 
cells are currently considered to offer potential for tissue re-
generation.  These include the obvious uses of cells to repair 
damaged tooth tissues such as dentine, periodontal ligament 
and dental pulp [16].  Even enamel tissue engineering has been 
suggested (Honda M. J. et al., 2009), as well as the use of dental 
stem cells as sources of cells to facilitate repair of non-dental 
tissues such as bone and nerves (Graziano A. et al., 2008).
The overall goal of tissue engineering is the functional 
restoration of tissue structures as well as the maintenance of 
the natural environment, and thus the viability and function of 
the damaged tissue due to disease or trauma.  In this context, 
dental replacement in clinical applications depends on the 
use of a potential material which would be anti-inflammatory, 
antibacterial and can simultaneously enhance the proliferation 
and induce the differentiation of present DPSC into odonto-
blast-like cells leading to dentin formation (Nakashima M., 
Reddi A. H., 2003).  Because of the similarities between dentin 
and bone structures, studies are often performed in dental 
tissue engineering in dependence on or in comparison to bone 
formation processes and applied osteoinductive materials. 
From a tissue engineering point of view it is noteworthy that 
there are differences between bone formation and a potential 
dentin formation as well.  Different approaches, which are also 
under investigation for maxillofacial surgery and partly for 
tooth tissue regeneration, can already be performed for bone 
reconstruction, such as: 1) An autologous graft from various 
donor regions comprising bone forming cells and growth 
factors and therefore being osteogenetic (Kneser U., Schaefer 
D. J., Polykandriotis E., Horch R. E., 2006); 2) An allograft and 
xenograft, respectively, i. e. a bone sample from other human 
beingsor from animals, which is osteoinductive due to certain 
proteins like growth factors (Richardson C. R., Mellonig J. 
T., Brunsvold M. A.); 3) Various osteoinductive biomaterials 
acting as carriers for growth factors inducing bone formation 
(Spiro R. C., Liu L. S., Heidaran M. A., Thompson A. Y., 2000); 
4) Synthetic bone substitutes for bone replacement without 
or with just partially resorption or for bone repair using os-
teoconductive porous devices.
The different autogeneic, xenogenetic and alloplastic bone 
replacement materials can be differentiated according to the 
functional quality of the new tissue and the dynamics of bone 
conversion thus induced.  Comparing osteoconductive bone 
substitutes with demineralised, osteoinductive materials and 
autogenic bone grafts, bone inducing matrices show the largest 
quantity of new bone formation.  In order to extrapolate the 
findings of bone to dentin repair, it is necessary to understand 
the dentin-pulp complex in more detail and in particular the 
challenging situation of the pulp itself especially in case of 
pulp healing and formation of reparative dentin.
In vitro studies, isolation and identification 
procedures of dental pulp cells
The proper isolation of cells provides the potential to 
differentiate into odontoblast-like cells.  A lot of experiments 
have shown that dental pulp cells can be isolated from human 
Nr. 3 (321), 2011
38
impacted third molars (14-29 years of age), which are extrac-
ted for clinical reasons under anaesthesia [5, 6, 7].  Tooth 
surface were cleaned by covering with 0.3% chlorhexidine 
gel [8, 9], swabbed with 70% (v/v) alcohol [10] or dipped 
carefully in 30% hydrogen peroxide for 30 to 120 sec.  Pulp 
was opened by cutting around the cementum enamel junction 
using sterilized dental fissure burs to reveal the pulp chamber 
[5].  Other studies describe that teeth were cracked opened, or 
opened by a dentinal excavator or a Gracey curette [7, 9].  After 
separation of the pulp tissue, cells can be isolated by various 
methods.  Pulp cells can be either isolated by digestion or the 
out-grown method [5, 9].  First, the pulp tissue can be digested 
in a solution of collagenase type I and dispase as reported in 
details by Gronthos S., et al. 2002 [5, 9].  The cell suspension 
is then centrifuged and pellets are suspended in Dulbecco’s 
modified Eagle’s medium (DMEM).  Single-cell suspensions 
can be obtained by passing the cells through 70 μm strainer 
and seeding into 6- well plates in DMEM supplemented with 
10-20% FCS, 100 μM ascorbic acid 2-phosphates, 2 mM L-
glutamine, 100 Units/ml penicillin and 100 μg/ml streptomy-
cin [5, 11, 12].  Secondly, pulp tissue explants (4 mm) were 
placed in 6-well plates and designated as human pulp cells/
out-grown method (HDPC-o).  These cells were cultivated to 
confluence in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% FBS and antibiotics [13].  Further, 
human pulp primary cultures (HPPc) could be obtained by 
mincing tissue fragments of extracted pulps into small pieces 
(< 1 mm), which were then placed in well plates containing 
RPMI 1640 medium-glutamax supplemented with 100 IU/
ml penicillin, 100 μg/ml streptomycin, 10 μg/ml amphoteri-
cin-B and 10% FCS [6, 7].  All cultures were maintained in a 
humidified atmosphere of 95% air and 5% CO2 at 37°C and 
medium change should be performed every two days.
Dental pulp cell cultivation
In order to develop a potential biomaterial for dental pulp 
regeneration and reconstitution of a complete dentin-pulp-
complex, the understanding of the proliferation as well as 
differentiation processes is indispensable.  Hence, studying 
processes in dental regeneration using an in vitro dental pulp 
cell culture system can provide an insight into biological 
processes which lead to odontoblast-like cell differentiation 
and induced dentin matrix mineralization.  Just based on a 
complete knowledge about in vitro dental pulp cell (DPC) 
behaviour and following in vivo experiments, conclusions 
can be drawn upon the requirements on the development 
of a highly suitable filling material.  The following section 
demonstrates whether it is possible to isolate a potential cell 
population comprising DPSC, and furthermore the prolife-
ration and differentiation ability has to be proven.
Proliferation and differentiation
Therefore, the first and critical step in order to investigate 
the proliferation and differentiation ability of these cells is 
the isolation of a suitable cell population.  DPC and DPSC, 
respectively, have already been isolated from adult human 
teeth (14-29 years of age) [5, 7, 9, 10, 11, 12, 13, 16], pork [14] 
and rat dental pulp [15].  A further cell culture system was 
obtained from human exfoliated deciduous teeth (SHED) (6-
10 years of age) [16, 9].  Miura M., et al. 2003 reasoned from 
his findings that SHED are distinct from DPSC because of a 
higher proliferation rate, increased cell-population doubling, 
and stem cell typical formation of spherical cell clusters and 
osteoinductive potential in vivo.  However, these cells do not 
maintain the capacity to reconstitute a dentin-pulp-complex 
for which reason there remain only mentioned [16].
Currently, two isolation methods are performed in various 
reports to isolate DPSC by either enzyme digestion, or the 
out-grown method, as described before Huang et al. investi-
gated whether cell isolation methods yield in the same pool 
of cell population.  Although the out-grown method is more 
convenient and not as technically extensive as the enzymatic 
digestion, cells migrate out of the tissue fragments growing 
slower than human DPC obtained by digestion method un-
til becoming confluent in 2-3 weeks [13].  Even enzymatic 
digestion may cause a cell damage; it allows different types 
of cells to form compact and loose types of colonies within 
1-2 weeks, which can separately be characterized [5, 13].  All 
cell cultures display a wide range of cell morphology such 
as fibroblast-like cells, endothelial-like or epithelial-like cell 
populations.  Gronthos S., 2002 have applied the enzyme 
digestion method and were able to demonstrate that dental 
pulp cells differentiated into odontoblast-like cells, which also 
formed dentin matrix in vivo [5, 18].  The out-grown method 
showed that cells are potentially capable to differentiate into 
odontoblasts or forming mineralized nodules in vitro [10, 11, 
17]. Concerning the growth behavior and characterization 
ability of single cell colonies the digestion method seems to 
be more reasonable.  Both methods demonstrated the ability 
to isolate cells containing a minor population of odontoblast 
precursor cells with typical criteria for postnatal somatic stem 
cells, such as their high rate of proliferation, clonogenic nature 
[5], and co-expression of specific markers.
Identification studies showed that DSPC express the cell 
surface antigen STRO-1, which is known to immunoselect 
osteogenic precursors in bone marrow stromal cells [5, 16, 
7].  Alliot-Licht et al. investigated the effect of dexamethasone 
contained in the differentiation medium resulting in a signi-
ficant increase of STRO-1 positive cell population in human 
DPSC [7].  Previous studies have demonstrated that isolated 
SHED cells proliferated in vitro contain approximately 9% of 
STRO-1 positive cell population [16].
These observations agree to that of Gronthos S., 2002 
demonstrating a similar percentage of about 5-6% of the 
total pulp cell population.  Further analysis revealed that 
DPSC express the perivascular cell marker CD146, but does 
not react with the hematopoietic markers CD14 (monocyte/
macrophage), CD45 (leucocyte) or CD34 (hematopoietic stem 
cells/endothelium).  To date there is no investigation published 
that demonstrates the effect of the applied isolation method 
on the yield of precursor cells in DPC.  After providing the 
evidence to isolate stem/progenitor cells out of the dental pulp, 
proliferation studies have been described in various reports 
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and exhibit a high proliferation rate.  The growth potential 
was beyond 100 population doublings and cell populations 
formed clonogenic cell clusters [5].
Studies have also demonstrated that cultures can be main-
tained after extensive subculturing of up to 20 passages after 
seeding isolated DPSC [5, 7].  After subculturing they are able 
to adhere quickly to conventional plastic dishes showing a 
typical fibroblastic, spindle-shape to polygonal morphology 
[10].
Conclusions
It is obvious that our knowledge in dental tissue engi-
neering is expanding rapidly, and existing data confirm a 
realistic feasibility of dental tissue repair in the near future. 
In this context it has been demonstrated that present dental 
pulp stem/progenitor cells have the ability to differentiate in 
vitro as well as in vivo into odontoblast-like cells.  Further-
more, the application of bioactive glasses incorporated into 
a biodegradable polymer matrix also seems to be a suitable 
material as a regenerating dental substitute.  The next step has 
to be the design of a “smart” and appropriate growth factors 
release system for diffusion through a residues dentin matrix 
after cavity preparation.
Future experiments should be focused on the design of a 
highly sophisticated biological based scaffold system, which 
would greatly improve tooth viability and health maintenance 
in dentistry including nanotechnologies, in particular, the 
material would provide stability and a stimulation effect on 
bone tissue formation.
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